Volume 117, Issue 3

Search all International Journal of Hematology articles

March 2023

Including PIH articles on Progress in pathophysiology and treatment of thrombocytopenia

Filter by

Volume:

Sort by

Date published:

New to old Old to new

21 articles in this issue

Detection of Candida albicans in the peripheral blood smear of a diffuse large B cell lymphoma patient
Shoya Arai
Takeshi Osawa
Haruko Tashiro
Images in Hematology 25 January 2023 Pages: 309 - 310
Inclusion of thymic Langerhans cell histiocytosis in the “5 Ts” of the differential diagnosis of anterior mediastinal mass
Kenichi Sakamoto
Kentaro Fujimori
Yoko Shioda
Images in Hematology 04 February 2023 Pages: 311 - 313
Progress in pathophysiological understanding and treatment of thrombocytopenia
Hirokazu Kashiwagi
Progress in Hematology 19 January 2023 Pages: 314 - 315
Recent progress in ITP treatment
Francesco Rodeghiero
Progress in Hematology 09 January 2023 Pages: 316 - 330
Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura
Masayuki Kubo
Masanori Matsumoto
Progress in Hematology 09 February 2023 Pages: 331 - 340
Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder
Laura M. Venier
Bianca Clerici
Donald M. Arnold
Progress in Hematology 27 December 2022 Pages: 341 - 348
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets
Si Jing Chen
Naoshi Sugimoto
Koji Eto
Progress in Hematology 27 December 2022 Pages: 349 - 355
Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia
Yukinori Nakamura
Takehiko Mori
Yasushi Onishi
Original Article 15 November 2022 Pages: 356 - 365
The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study
Yoshitaka Miyakawa
Kazunori Imada
Masanori Matsumoto
Original Article Open access 24 November 2022 Pages: 366 - 377
Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy
Chia-Yau Chang
Shiue-Wei Lai
Yeu-Chin Chen
Original Article 04 December 2022 Pages: 378 - 387
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies
Ana C. Oliveira
Josep Maria Roncero
Eva González-Barca
Original Article 30 November 2022 Pages: 388 - 397
Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia
Masamitsu Yanada
Satoshi Yamasaki
Shingo Yano
Original Article 06 November 2022 Pages: 398 - 408
A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis
Koji Kato
Nobuharu Fujii
Kiyohiko Hatake
Original Article 18 November 2022 Pages: 409 - 420
Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors
Ryu Yanagisawa
Tsuneaki Hirakawa
Nobuhiro Tsukada
Original Article 20 November 2022 Pages: 421 - 427
Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience
Mengni Guo
Jieying Liu
Shahram Mori
Original Article 15 November 2022 Pages: 428 - 437
Endothelial function testing before conditioning therapy is useful for predicting transplant-related complications after allogeneic hematopoietic cell transplantation
Shojiro Haji
Motoaki Shiratsuchi
Yoshihiro Ogawa
Original Article 27 November 2022 Pages: 438 - 445
Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment
Nihal Karadaş
Şerife Şebnem Önen Göktepe
Deniz Yilmaz Karapinar
Original Article 19 November 2022 Pages: 446 - 455
Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency
Michael J. Hochman
B. Douglas Smith
Amy E. DeZern
Case Report 01 October 2022 Pages: 456 - 462
Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion
Takashi Oyama
Kazuki Taoka
Mineo Kurokawa
Case Report 06 October 2022 Pages: 463 - 467
Correction to: Refined ultrasonographic criteria for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation
Mutsumi Nishida
Junichi Sugita
Takanori Teshima
Correction 17 February 2023 Pages: 468 - 468
Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series
Yoshinobu Kanda
Takehiko Mori
Kazuma Nishimura
Correction Open access 25 January 2023 Pages: 469 - 469

Volume 117, Issue 3

Detection of Candida albicans in the peripheral blood smear of a diffuse large B cell lymphoma patient

Inclusion of thymic Langerhans cell histiocytosis in the “5 Ts” of the differential diagnosis of anterior mediastinal mass

Progress in pathophysiological understanding and treatment of thrombocytopenia

Recent progress in ITP treatment

Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura

Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder

Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets

Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia

The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study

Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies

Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia

A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis

Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors

Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience

Endothelial function testing before conditioning therapy is useful for predicting transplant-related complications after allogeneic hematopoietic cell transplantation

Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment

Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency

Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion

Correction to: Refined ultrasonographic criteria for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation

Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series

Navigation